| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $340,956 ) |
| | 2023 | 2023 | AGEX THERAPEUTICS INC | 1101 MARINA VILLAGE PKWY | ALAMEDA | CA | 94501-6472 | ALAMEDA | USA | R41HL170875 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery Disease | 000 | 1 | NIH | 8/11/2023 | $340,956 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2018 | AGEX THERAPEUTICS INC | 1101 MARINA VILLAGE PKWY | ALAMEDA | CA | 94501-6472 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 000 | 1 | NIH | 8/29/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | AGEX THERAPEUTICS, INC. | 965 ATLANTIC AVE STE 101 | ALAMEDA | CA | 94501-1079 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 001 | 1 | NIH | 4/14/2021 | $0 |
| | 2021 | 2018 | AGEX THERAPEUTICS, INC. | 1101 MARINA VILLAGE PKWY STE 201 | ALAMEDA | CA | 94501-6472 | ALAMEDA | USA | R43AR074351 | Metabolically Reprogrammed Mesenchymal Stem Cells for Treating Osteoporosis | 000 | 1 | NIH | 11/9/2020 | $0 |
| | 2021 | 2018 | AGEX THERAPEUTICS, INC. | 965 ATLANTIC AVE STE 101 | ALAMEDA | CA | 94501-1079 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 000 | 1 | NIH | 2/4/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $385,923 ) |
| | 2020 | 2018 | AGEX THERAPEUTICS, INC. | 965 ATLANTIC AVE STE 101 | ALAMEDA | CA | 94501-1079 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 001 | 1 | NIH | 4/8/2020 | $385,923 |
|
| Issue Date FY: 2018 ( Subtotal = $224,973 ) |
| | 2018 | 2018 | AGEX THERAPEUTICS, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R43AR074351 | Metabolically Reprogrammed Mesenchymal Stem Cells for Treating Osteoporosis | 000 | 1 | NIH | 9/20/2018 | $224,973 |
|
|
